title: Camel milk as an adjunct to insulin therapy improves long-term glycemic control and reduction in doses of insulin in patients with type-1 diabetes A 1 year randomized controlled trial.
authors.forename: R P
authors.initials: RP
authors.lastname: Agrawal
authors.forename: R
authors.initials: R
authors.lastname: Beniwal
authors.forename: D K
authors.initials: DK
authors.lastname: Kochar
authors.forename: F C
authors.initials: FC
authors.lastname: Tuteja
authors.forename: S K
authors.initials: SK
authors.lastname: Ghorui
authors.forename: M S
authors.initials: MS
authors.lastname: Sahani
authors.forename: S
authors.initials: S
authors.lastname: Sharma
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000187:drug effects / Q000502:physiology; D015992:Body Mass Index; D002096:C-Peptide / Q000097:blood; D002162:Camelus / Q000378:metabolism; D003131:Combined Modality Therapy / Q000379:methods; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005215:Fasting / Q000097:blood; D006442:Glycated Hemoglobin / Q000737:chemistry; D006801:Humans; D007328:Insulin / Q000097:blood / Q000627:therapeutic use*; D007330:Insulin Antibodies / Q000276:immunology; D007774:Lactation; D008892:Milk / Q000737:chemistry / Q000378:metabolism*; D010361:Patients; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D007328:Insulin; D007330:Insulin Antibodies